FLEXIBLE DESIGN FOR NOVEL TRIALS: Cenduit Supports National Lung Cancer Trial The following case study describes a biomarker directed umbrella trial built with a flexible IRT framework that accelerates development, validation and deployment of protocol changes while keeping trial sponsors in compliance and patients safe.Background Cenduit currently provides randomization and trial supply management for the world’s largest precision medicine trial to investigate treatment for non-small cell lung cancer. This trial is investigating genetic biomarker targeted therapy combinations, via partnership between non-profit research organizations and large pharmaceutical companies Clinical Research Program This umbrella trial is comprised of six distinct mini studies running within, with a

Join for free to read